Increased expression of HES6 has been detected in various tumors, including advanced astrocytoma, glioblastoma, prostate cancer, leukemia, gastric cancer, colon cancer, breast cancer, lung cancer, and kidney cancer and is associated with poor survival 37-41. This evidence concerns the gene HES6 and breast carcinoma.